Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure

Mayo Clinic Proceedings

Volumn 78, Issue 4, 2003, Pages 481-486

  Shapiro, Brian P ^a   Chen, Horng H ^a   Burnett Jr , John C ^a   Redfield, Margaret M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; FOOD AND DRUG ADMINISTRATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; SHORT SURVEY; TIME; TRIAGE BNP TEST;

EID: 0037381602     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/78.4.481     Document Type: Short Survey

References (16)

1. Lloyd-Jones DM. The risk of congestive heart failure: sobering lessons from the Framingham Heart Study. Curr Cardiol Rep. 2001;3:184-190.
2. Redfield MM. The Breathing Not Proper Trial: enough evidence to change heart failure guidelines? J Card Fail. 2002;8:120-123.
3. Senni M, Redfield MM. Heart failure with preserved systolic function: a different natural history? J Am Coll Cardiol. 2001;38:1277-1282.
4. McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 1997;350:829-833.
5. Remme WJ, Swedberg K, European Society of Cardiology. Comprehensive guidelines for the diagnosis and treatment of chronic heart failure: task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail. 2002;4:11-22.
6. Davis M, Espiner E, Richards G, et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet. 1994;343:440-444.
7. Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 1997;350:1349-1353.
8. Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol. 2001;37:379-385.
9. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002;106:416-422.
10. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.
11. Wright SP, Gamble GD, Pearl A, et al. The use of brain natriuretic peptide in the diagnosis of heart failure in the community: a randomised, controlled, effectiveness study [abstract]. J Card Fail. August 2002;8(suppl):S13. Abstract 044.
12. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings [published correction appears in Circulation. 2002;106:387]. Circulation. 2002;105:595-601.
13. Villacorta H, Campos A, Duarte N, Martins MV, Mesquita ET. The utility of B-type natriuretic peptide in the diagnosis of heart failure with preserved systolic function in patients presenting to the emergency department with dyspnea [abstract]. J Card Fail. August 2002;8(suppl):S28. Abstract 100.
14. Cabanes L, Richaud-Thiriez B, Fulla Y, et al. Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea. Chest. 2001;120:2047-2050.
15. Cataliotti A, Malatino LS, Jougasaki M, et al. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc. 2001;76:1111-1119.
16. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40:976-982.